or as a single agent after one or more prior lines of systemic therapy for patients with tumors of squamous cell histology that express PD-L1 (CPS ≥10) as determined by an FDA-approved test and also ...

The following is a summary of “Multimodality Therapy Including Pleurectomy/Decortication in Pleural Mesothelioma: Long-Term ...

LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...

Clin Lung Cancer. 2010;11(1):30-35. A total of 294 treatment cycles were administered to the 62 patients, with a median number of 6 cycles per patient (range, 1–6 cycles). Of 62 patients, 56 ...

Veterans are the most affected by asbestos and mesothelioma. A centralized database for veterans exposed to asbestos to help fight this.

Subepithelial lesions (SLEs) are often detected incidentally during endoscopic examination. They represent a heterogeneous ...

Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...

Almost 80% of malignant tumors in the kidney are ccRCC, and the 5-year survival rate remains disappointing. Current standard of care is a combination of drugs that target vascular growth factor ...

Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...